Navigation Links
HIV 'Cure' Looks 'Promising,' Danish Scientists Contend
Date:4/29/2013

MONDAY, April 29 (HealthDay News) -- Danish scientists testing a novel HIV treatment in human trials contend that they're confident their strategy will result in a cure for the AIDS-causing virus, according to news reports.

The technique -- already tested successfully in lab experiments -- involves freeing the HIV virus from DNA cells, where it collects in "reservoirs," and bringing it to the surface of the cells, the Telegraph in Great Britain reported. Once the virus has surfaced, it can be permanently destroyed by a "vaccine" that primes the body's natural immune system, the researchers said.

"I am almost certain that we will be successful in releasing the reservoirs of HIV," said Dr. Ole Sogaard, a senior researcher at the Aarhus University Hospital in Denmark, according to the news report. So far the clinical trials are "promising," he said.

Human clinical trials are under way, said Sogaard, adding that early signs are "promising. I am almost certain that we will be successful in releasing the reservoirs of HIV," he said.

Fifteen patients are currently taking part in the trials, and if they are found to have successfully been cured of HIV, the "cure" will be tested on a wider scale, the Telegraph reported.

"The challenge will be getting the patients' immune system to recognize the virus and destroy it. This depends on the strength and sensitivity of individual immune systems," Sogaard said, the newspaper reported.

Sogaard said a "cure" is different than a preventative vaccine. That means continued awareness of unsafe behaviors -- such as avoiding unprotected sex or sharing needles for intravenous drug use -- is still the key to combating HIV.

If the Danish researchers are successful, it would obviously represent a huge step in the battle against HIV.

A large study of an experimental HIV vaccine was halted recently because the shots weren't preventing infection, the U.S. National Institutes of Health said last week.

The clinical trial included about 2,500 people, mostly gay men, in 19 cities. Half of the participants were given the vaccine developed by the NIH and half received placebo shots. A safety review found that slightly more people who had received the vaccine later became infected with HIV. The reasons for this aren't clear.

While the vaccinations are being stopped, the NIH said it will continue to track the study participants' health, the Associated Press reported.

Numerous attempts to develop an HIV/AIDS vaccine have failed.

More information

To learn more about HIV, visit the U.S. National Library of Medicine.

-- HealthDay staff

SOURCES: Telegraph, April 27, 2013; Associated Press


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fish Pedicure a Recipe for Bacterial Infection, Researchers Warn
2. Arizona State University secures defense contract
3. Pornography and Masturbation Addiction Can Be Cured – Las Vegas Therapist Shares His Ideas
4. OnPage Provides Secure, Rapid Response at New England’s Largest Catholic Hospital
5. Prevention is better than cure for killer cardiovascular disease
6. Researchers develop secure protocol for linking data registries for HPV surveillance
7. 23andMe acquires CureTogether, Inc.
8. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
9. Can gene therapy cure fatal diseases in children?
10. AACR, Komen for the Cure honor researcher with lecture on science of cancer health disparities
11. Many Mistakenly Think Radiation Might Cure Terminal Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV 'Cure' Looks 'Promising,' Danish Scientists Contend
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical ... innovative solutions for injectable drug administration, today shared the ... ID Adapter for improving the intradermal administration of polio ... Skin Vaccination Summit in May 2017 by Dr. ... Polio Department, World Health Organization (WHO), and recently published ...
Breaking Medicine Technology: